Patient characteristics and opioid use prior to discharge after open gynecologic surgery in an enhanced recovery after surgery (ERAS) program
- PMID: 30902370
- PMCID: PMC7066503
- DOI: 10.1016/j.ygyno.2019.03.101
Patient characteristics and opioid use prior to discharge after open gynecologic surgery in an enhanced recovery after surgery (ERAS) program
Abstract
Objective: To identify clinical and demographic characteristics associated with the absence of opioid usage on the day before discharge among patients undergoing open gynecologic surgery within an enhanced recovery after surgery (ERAS) program.
Methods: This was a single institution retrospective cohort study including all patients who underwent elective open gynecologic surgery as part of an ERAS program between November 1, 2014 and September 30, 2018 and who were discharged between post-operative day 2 and 7. Patients were excluded if they reported pre-existing chronic opioid use or underwent total pelvic exenteration. Descriptive statistics were used and multivariable logistic regression was used to identify factors associated with the absence of opioid usage on the day before discharge, after adjustment for relevant covariates.
Results: A total of 971 were included with a median length of stay of 3 days, and of these 526 (54.2%) used opioids on day before discharge and 445 (45.8%) did not. Absence of opioid use on the day before discharge was associated with age (P < .001), race (P = .04), Charlson Co-morbidity Index (P < .001), marital status (P = .004), and smoking status (P = .002) by univariate analysis. In a multivariable model, older age (adjusted OR 1.04; 95% CI 1.02-1.06; P < .001), current smoker status (adjusted OR 0.42; 95% CI 0.20-0.81; P = .01), and white or Caucasian race (adjusted OR 0.59; 95% CI 0.38-0.91; P = .02) were significantly associated with the absence of opioid use on the day prior to discharge.
Conclusions: Nearly half of patients undergoing open gynecologic surgery within an established ERAS program did not consume any opioids on day before discharge. Safe, evidence-based reductions in post-operative opioid prescribing may be feasible for a subset of gynecologic surgery patients.
Keywords: ERAS; Opioids; Surgery.
Copyright © 2019. Published by Elsevier Inc.
Conflict of interest statement
Conflict of interest
The authors report no conflict of interest.
Figures
Similar articles
-
Postoperative Opioid Use Using Enhanced Recovery After Surgery Guidelines for Benign Gynecologic Procedures.J Minim Invasive Gynecol. 2020 Feb;27(2):510-517. doi: 10.1016/j.jmig.2019.04.017. Epub 2019 Apr 17. J Minim Invasive Gynecol. 2020. PMID: 31004796
-
Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes.Obstet Gynecol. 2018 Aug;132(2):281-290. doi: 10.1097/AOG.0000000000002735. Obstet Gynecol. 2018. PMID: 29995737 Free PMC article.
-
Enhanced Recovery After Surgery in Pediatric and Adolescent Gynecology: A Pilot Study.J Pediatr Adolesc Gynecol. 2020 Aug;33(4):403-409. doi: 10.1016/j.jpag.2020.02.001. Epub 2020 Feb 12. J Pediatr Adolesc Gynecol. 2020. PMID: 32061749
-
Enhanced Recovery after Minimally Invasive Gynecologic Procedures with Bowel Surgery: A Systematic Review.J Minim Invasive Gynecol. 2019 Feb;26(2):288-298. doi: 10.1016/j.jmig.2018.10.016. Epub 2018 Oct 24. J Minim Invasive Gynecol. 2019. PMID: 30366117
-
ERAS implementation in an urban patient population undergoing gynecologic surgery.Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85(Pt B):1-11. doi: 10.1016/j.bpobgyn.2022.07.009. Epub 2022 Aug 7. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 36031533 Review.
Cited by
-
Development and Validation of a Model for Opioid Prescribing Following Gynecological Surgery.JAMA Netw Open. 2022 Jul 1;5(7):e2222973. doi: 10.1001/jamanetworkopen.2022.22973. JAMA Netw Open. 2022. PMID: 35857323 Free PMC article.
-
Enhanced recovery for obese patients undergoing gynecologic cancer surgery.Int J Gynecol Cancer. 2020 Oct;30(10):1595-1602. doi: 10.1136/ijgc-2020-001663. Epub 2020 Aug 26. Int J Gynecol Cancer. 2020. PMID: 32848023 Free PMC article.
-
Longitudinal patient-reported outcomes and restrictive opioid prescribing after minimally invasive gynecologic surgery.Int J Gynecol Cancer. 2021 Jan;31(1):114-121. doi: 10.1136/ijgc-2020-002103. Epub 2020 Nov 6. Int J Gynecol Cancer. 2021. PMID: 33158876 Free PMC article.
-
No increase in chronic kidney disease after postoperative acute kidney injury in gynecologic oncologic ERAS surgery.Gynecol Oncol. 2025 Jul;198:168-175. doi: 10.1016/j.ygyno.2025.06.002. Epub 2025 Jun 11. Gynecol Oncol. 2025. PMID: 40505183
-
Impact of a tiered discharge opioid algorithm on prescriptions and patient-reported outcomes after open gynecologic surgery.Int J Gynecol Cancer. 2021 Jul;31(7):1052-1060. doi: 10.1136/ijgc-2021-002674. Epub 2021 Jun 16. Int J Gynecol Cancer. 2021. PMID: 34135073 Free PMC article.
References
-
- Thompson JC, Komesu YM, Qeadan F, Jeppson PC, Cichowski SB, Rogers RG, et al., Trends in patient procurement of postoperative opioids and route of hysterectomy in the United States from 2004 through 2014., Am. J. Obstet. Gynecol 219 (2018) 484.e1–484.e11.doi:10.1016/j.ajog.2018.07.003. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources